Essilor, Agreement with Nanotechnologies, Inc.

Harris & Harris Group noted the last week that Nanotechnologies, Inc., a technology leader in high-performance nanoparticles, has announced that it has entered into a development agreement for eyewear applications with Essilor, the world leader in ophthalmic lenses. Harris & Harris Group owns a fully diluted 6.48% interest in Nanotechnologies, Inc.

Harris & Harris Group is a publicly traded venture capital company. The Company now makes initial investments exclusively in tiny-technology enabled companies, and its last 10 initial private equity investments have been in such companies. Harris & Harris Group, Inc. is a Business Development Company with 11,498,845 common shares outstanding.